Basic information
Biomarker: SPAG9
Histology type: endometrioid endometrial carcinoma
Stage: Grade 1
Cohort characteristics
Country: China
Region: Shandong
Study type: prospective study
Followed up time :
Subgroup 1 name : Grade 1 Endometrioid Adenocarcinoma
Subgroup 1 number: 8
Subgroup 2 name: Endometrial Hyperplasia
Subgroup 2 number: 19
Total number | Group I | Group I number | Group II | Group II number | Group III | Group III number | Group IV | Group IV number |
---|---|---|---|---|---|---|---|---|
27 | Grade 1 Endometrioid Adenocarcinoma | 8 | Endometrial Hyperplasia | 19 |
Sample information
Conclusion: SPAG9 may be associated with the efficacy of progestin treatment in CAEH and grade 1 EA. It may help to distinguish CAEH from grade 1 EA and serve as a new prognostic marker of CAEH or grade 1 EA treated with progestin.
Sample type : tissue
Sample method: immunohistochemistry
Expression elevation: Evaluation of immunohistochemistry was scored by extent (the positive frequency of endometrial gland) and its intensity. The staining intensity was estimated on a four-step scale (0 = no staining; 1 = weak staining; 2 = moderate staining; 3 = strong staining).The fraction of stained gland was scored based on the following criteria: score 0 (0–10% positive endometrial gland), score 1 (11–50% positive endometrial gland), score 2 (51–80% positive endometrial gland), score 3 (>80% positive endometrial gland). The final score were the product of the above two scores.
Disease information
Related information
Funtion Uniprot: The JNK-interacting protein (JIP) group of scaffold proteins selectively mediates JNK signaling by aggregating specific components of the MAPK cascade to form a functional JNK signaling module (PubMed:14743216). Regulates lysosomal positioning by acting as an adapter protein which links PIP4P1-positive lysosomes to the dynein-dynactin complex (PubMed:29146937). Assists PIKFYVE selective functionality in microtubule-based endosome-to-TGN trafficking (By similarity).
UniProt ID: O60271
UniProt Link: https://www.uniprot.org/uniprotkb/O60271/entry
Molecular function from UniProt:
Tissue specificity from UniProt: Expressed only in testis on the round spermatids of stage I, II and II. Absent in spermatogonia and spermatocyte. Isoform 4 Expressed in testis and in acute myeloid leukemia (AML) patients. Isoform 3 Expressed in testis.
Subcellular UniProt: #Cytoplasm #Cytoplasmic vesicle #Lysosome #Membrane
Alternative name from UniProt:
Activity regulation: Isoform 5 May play a role in spermatozoa-egg-interaction.
Recommended name: C-Jun-amino-terminal kinase-interacting protein 4
Gene name from HGNC: SPAG9 (CT89, FLJ13450, FLJ14006, FLJ26141, FLJ34602, HLC4, HSS, JIP-4, JIP4, JLP, KIAA0516, MGC117291, MGC14967, MGC74461, PHET, PIG6, SYD1)
HPA class: Plasma proteins
AlphaFold DB: O60271
AlphaFold Link: https://alphafold.ebi.ac.uk/entry/O60271
HPA link: https://www.proteinatlas.org/ENSG00000008294-SPAG9
Tissue specificity RNA from HPA: Low tissue specificity
Tissue expression from HPA: Ubiquitous cytoplasmic expression.
Single cell type specificity Low cell type specificity
Immune cell specificity: Group enriched (neutrophil, basophil)
Subcellular summary HPA Located in Centriolar satellite, Cytosol
Cancer prognostic summary HPA Prognostic marker in urothelial cancer (unfavorable)
Pathology link: https://www.proteinatlas.org/ENSG00000008294-SPAG9/pathology
Pathology endo: https://www.proteinatlas.org/ENSG00000008294-SPAG9/pathology/endometrial+cancer
OMIM: 605430
OMIM link2: https://www.omim.org/entry/605430
HGNC ID: HGNC:14524
HGNC link: https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:14524